AST Asterias Biotherapeutics Inc. Common Series A

0.71
0  -0%
Previous Close 0.71
Open 0.72
Price To Book 1.61
Market Cap 39506534
Shares 55,658,684
Volume 96,541
Short Ratio 1.42
Av. Daily Volume 223,362

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1 data due 2019 and 2020.
AST-VAC2
Non-small cell lung cancer (NSCLC)
Phase 1/2 12-month data from cohorts 3 and 4 released July 31, 2018 with 12-mth data from all cohorts due 1Q 2019.
AST-OPC1 SCiSTAR
Cervical spinal cord injury
Phase 2b planned for 2018.
AST-VAC1
Acute myeloid leukemia (AML)